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Multiple Comparison among Groups of
Growth Curves
by Toshinari Kamakura' and Tsuyoshi Takizawa2
Theproblemofcomparingasequenceofindependentexperimentsdividedintoseveralgroupswithacontrolisdiscussed
underthelogisticgrowth-curvemodels. Weproposeamethodforconstructingmultipletestingproceduresusingtheclosed
testing procedures and therandom-effect model for summarizing estimated values ofparameters.
Introduction
Intoxicological studiesitisofgreatimportance toevaluateside
effects ortoxicity ofnewdrugs, industrial compounds, and en-
vironmental contaminants. We are interested ininvestigating the
maximum doselevelsbelow which notoxicity isobserved or, if
a maximum level exists, ifit is tolerable. We call this level the
maximumnoneffectivedose(MNED). Ruberg (1)considersthe
problemsofinferenceabouttheminimumeffectivedose(MED)
bycomparingvarious dose groupswith acontrolandreachesthe
conclusionthatthesimulationstudieshavesuperiorcontrast pro-
cedurescompared totheothermultiplecomparisonprocedures
(2,3). Ifwedesign anexperimentinwhichdifferences indoses
among groups aresmall, MNEDandMED arealmostthe same.
In this article we focus on inferring the MNED from the view-
point ofa safe dose.
In the usual dose-response studies we can use the standard
multiplecomparisontechniques asdescribed above. However,
itisdifficult toapplythemin caseswherethe responses are con-
tinuallyobservedwithconstant exposureto somedoseleveland
whentheobservations arearranged onthetimeaxisforeach ex-
periment. The problem is how we can select the time point at
whichto comparethetwogroups. Evenifweselectonepointfor
comparison, we mayloseotherinformation suchthattheobser-
vations of one group are always fewer than those ofthe other
groups. This situation is illustrated in the Figure 1. We are in-
terested incomparing groups inwhicheachanimal isobserved
continually, and we propose amultiplecomparisontechnique for
these types ofdata sets.
Growth-Curve Modeling and
Maximum Noneffective Dose
Suppose we have the following data sets:
{Xujk;i = 1,..,,a;j = 1, ..., n;k =1 T}
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FIGURE 1. Difficulty incomparing data sets arranged on a time axis.
The subscripts i,j, andkmean, respectively, the ith group,jth
individual in each group, and kth observation for the each in-
dividual on the time axis. For example,xjk is the weightofthe
jth animal attimekintheith group. Weassume zero dose for i
= 0asacontrolgroupandthatdoselevelincreasesmonotonous-
ly with index i.
Ourmainpurpose is tocomparetheweightcurves observed
onthetimeaxisforeachanimalinthe(a + 1)groups. Wewould
liketoknowwhetherthereareanydifferences inweightcurves
amongdosegroups. Canwedrawthelinethatdiscriminatesthe
dose level below which we may conclude no effects or no
obstructions ingrowthsandcompareittothecontrolgroup?This
questiondrivesustoinvestigatethemaximumnoneffectivedose
statistically. Yoshimura(4)considersthisproblemwithnotime-
dependentobservationsfromtheviewpointofthestandardmulti-
ple comparisons. However, we cannot extend those multiple
comparisontechniquestotheproblemofweightcurves. Firstwe
willfitsomegrowthcurvemodelwithafewparametersandsec-
ondwewillcomparethederivedestimatesoftheseparameters.
We assume the logistic growth curves as weight curves for
animals, which is describedas follows:
=
1 +e-f(tj+IA) +es (j = (2)
Here e is independently normally distributed with mean0 and
variance &l. Note that the indexes i and k are omitted forKAMAKURA AND TAKIZAWA
simplicity. TheparameterKisinterpreted asthefinalweightof
ananimal withconstantexposuretoadoseofsomelevel. Sothe
estimate ofKis one ofourprimary interests. We first compute
the estimates by maximizing the likelihood,
__ i K ~2]
L=J 7V[i [ a j 1 +e-p(t,+A) ] (3)
foreachindividual. Infact, wemustsolvethen(a + 1)likelihood
equations. Then wewouldobtain4n(a + 1)parameterestimates,
{Ifij)pijX Aieaj}( 07 11 ... a; j = ,...n)
and theirasymptotic variances. Inthefollowing section wepro-
pose a method to summarize these estimates for multiple
comparisons.
Multiple Comparisons by Random-
Effects Model
It is useful to use a random-effect model for summarizing
estimatedvariables foreachgroup. KomandWhittemore(5)use
the random-effect model forobtainingoverall estimates assum-
ing a multiple logistic model for eachpatient.
We assumethatKijisnormally distributed with meanKijand
variance a, and that Kij and mq are obtained by solving the
following likelihood equations:
J~~~ =0 JE or?.+77? °
1 .n (K +ij j)2 _=1 E o?1j + -o (4)
In these equations we can use the asymptotic variances ofKiR,
V, as the variances aj. The asymptotic variances and
covariances ofKi and ?i? are calculated as follows:
Avar(ki1) =
Avar(fi) = ( 1 (aT.j + 5?)2
l ACov(fi,7)= 0
Now we would like to obtain the MNED level by multiply
comparing the estimates [Ki i = 0, . . .,a]. First we consider
theproblemofthehypothesistesting wherethenullhypothesis is
to: }ho = K, * Ifa .
We define that
r = (KoIfo , ... IKa)
Then the null hypothesis is expressed as follows:
Ho: Cr = o,
where the matrix C[a x (a + 1)] is as follows:
1 -1 0 ... 0
C= I -1 ... 0
1 0 0sait -1
We considerthefollowing test statistic.
T = (Cr')' {CV(r')C'}-1 (Cr) (6)
TheoperatorSbisusedtogenerate thecovariancematrix ofthe
vectorargument. Inourcasethecovariancematrixisasimple,
diagonal matrix whose elements correspond to the asymptotic
variances. Underthenullhypothesis, thestatisticgivenbyEqua-
tion6hasasymptotically achi-squaredistribution withadegrees
of freedom. For multiple comparison we can use the closed-
testing proceduresproposedby Marcusetal. (6), which require
thatsetsofhypothesesareclosedunderintersectionandthateach
test is oflevel a. Then wecan assure that the overall error rate
is less than a ifwe use these multiplecomparisonprocedures.
We consider the following set of hierarchical hypotheses
closed under intersection:
H1: Ifo = I,
H2 : Ifo = K1 = K2
Ha: Io = I =IK2 = =K.
The closed procedures are constructed by testing each null
hypothesis with alevela andfindingthehypothesis Hxo; HXfor
X < Xois notrejectedandHxforX > Xois rejectedwith alevel
a. Here we can use the test statistic (Eq. 5) foreach test.
Examples
We consider two examples in which a new drug is tested for
toxicity. Thefirstdataaremalebodyweights (grams) foracon-
trolandadosegroup(200mg/kg) froma5-weektoxicity study
in rats. The summary statistics are shown inTable 1.
What troubles toxicologists is that the control versus dose
groupcomparisonshowssignificantdifference atdays4-32 and
butisnotsignificantatday35bythef-test. Shouldtheyconclude
significance or nonsignificance? We estimate the final body
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Table 1. Summary ofstatisticsofcontrolanddosegroups.
Day
Group 0 4 7 11 14 18 21 25 28 32 35
Control Mean 121.1 158.4 186.0 218.6 241.1 273.6 293.4 320.8 334.8 355.7 361.4
(n = 9) SE 1.3 2.4 2.5 3.6 4.2 5.2 6.2 7.0 7.5 8.8 9.7
Dose Mean 122.4 152.4 173.4 203.0 225.5 255.0 275.9 297.4 309.0 330.4 337.8
(n = 10) SE 1.5 1.6 2.0 2.5 3.3 3.6 4.2 5.3 5.2 6.4 6.6
weights KVaIU"S in the random-effects model. The mean K is
402.20 g forthe control and 382.72 g forthe dose group. The
test statistic of Equation 6 with a = 1 results in 1.53, and
therefore we can conclude thatthe two groups are not signifi-
cantly differentfromtheviewpointofthefinalestimatedbody
weights compared to the upper probability of chi-squared
distribution with 1 degree offreedom.
Second, wechooseforillustrationthedatasetconsisting ofa
control groupandfourdosegroups: foreachgroup, weightsof
16 rats weretakenat27timepoints. Dosegroups levelsare 15,
35, 85, and200 mg/kg. Figure 2 shows the plotsofgrowth of
16 rats in 15 mg/kg dosegroup.
The estimate of the final body weight and its asymptotic
variance ineachgroup aregiven inTable2. Table 3 showsthe
valuesofstatisticsobtainedfromEquation6. Fromthetable, we
can find thatthe dose group of200 mg/kg is significantly dif-
ferent fromthe control group in thefinal body weight.
Sometimes laboratoryworkers makeanerrorinadminister-
ingdrugstoratsandhurttherats' throats. Subsequentlytherats
Table2. Estimated final weights (grams) andtheirasymptotic variances.
Group number ^ AVar(K-)
0 547.849 72.907
1 557.207 95.282
2 556.211 181.048
3 530.379 119.401
4 459.725 136.771
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FIGURE2. Superimposed individual plots forthe 15 mg/kgdosegroup.
Table3. The values ofchi-square statistics.
Hypothesis x2
1 0.5206
2 0.6040
3 3.8614
4 51.4473
will noteatfood, and they lose weight. Ifwecome across this
kindofsuspiciousdata, wecanremovetheobservationsthatare
verified as abnormal by laboratory workers and continue to
analyze the remaining data set. Forexample, in our data set a
malerateofthe200mg/kgdosegrouphadanabnormally large
weightlossatday91. Ifwedeletethisobservationatthispoint,
wecanobtaintheslightly smallerchi-squarevalueof50.769in
comparisonwith51.447,whichisgiveninthelastrowinTable
3. In this example we can conclude that the dose group of85
mg/kg is the MNED with regard to the finalbody weights.
Conclusion and Discussion
Wediscussedthemultiplecomparisonproblemsofparameter
estimatesassuminglogisticgrowth-curvemodelsjointlyusing
arandom-effectmodelandtheclosedprocedure. Itisimportant
tobuildamodelthatincludesonlyafewparameterstoavoidthe
difficulty ofhandlingmultiplicity oftheobservationtimepoints:
It is similarto theproblem fordetecting atrend. We assumed
normalities forusingtherandom-effectsmodelinthispaper, but
itisbettertocheckthenormalitiesofparameterestimates. This
may result indevising anewtechnique fordataanalysis using
random-effects models.
Someresearchersmightopposeusingthisapproachtofinding
MNEDor MED by multiple testing procedures. Suppose that
noeffectsareobservedwithin somedoselevelinmechanismA
but that a small effect is observed within this dose level in
mechanismB. AsformechanismB, wesometimesconsiderthe
effectnotimportantcomparedtocuringadiseasewiththatdrug.
Inaddition, ifwehavealargeenoughdataset, wecandetectthe
verysmalleffects. Statistically speaking, wedonotdistinguish
betweenmechanismAandBifwedonotfindanysignificance.
Therefore, wemustnotethatthederivedMNEDisastatistical
result andthatit stronglydepends onthe samplesize. Further
research wouldbe needed to find theMNED.
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